# Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation

> **NCT00058188** · PHASE3 · TERMINATED · sponsor: **Northwestern University** · enrollment: 53 (actual)

## Conditions studied

- Osteoporosis
- Prostate Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** cholecalciferol
- **DRUG:** calcium gluconate
- **DRUG:** zoledronic acid

## Key facts

- **NCT ID:** NCT00058188
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-03
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 53 (ACTUAL)
- **Why stopped:** Closed by the research committee
- **Last updated:** 2020-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00058188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00058188, "Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00058188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*